AHA Urges HHS to Take Action Against Drug Manufacturers for Limiting the Distribution of 340B Drugs

July 30, 2020

AHA expresses concern regarding recent action taken by three major drug manufacturers – Eli Lilly and Co., Merck and Sanofi – to limit the distribution of certain 340B drugs to our hospital members. Eli Lilly has filed its notice to limit the distribution of certain 340B drugs with the Office of Pharmacy Affairs within the Health Resources and Services Administration (HRSA). Merck and Sanofi have directly communicated with our 340B hospital members requesting detailed information about any 340B drugs distributed through the hospital’s contract pharmacy arrangements. The Merck and Sanofi communications explain the purpose of the request is to investigate possible duplicate discounts provided to state Medicaid programs.  We urge HRSA to address these abuses by Merck, Eli Lilly and Sanofi and request they cease this activity and work to ensure that 340B drugs are available and accessible to communities and vulnerable populations. 

Related Resources

Special Bulletin
The Centers for Medicare & Medicaid Services (CMS) today released the calendar year (CY) 2021 outpatient prospective payment system (OPPS)/ambulatory…
Special Bulletin
Public
President Trump today signed three executive orders aimed at lowering the price of prescription drugs. The first executive order seeks to pass federally-…
Letter/Comment
July 20, 2020 The Honorable Seema Verma Administrator Centers for Medicare & Medicaid Services Hubert H. Humphrey Building 200 Independence Avenue, S.W.,…
Special Bulletin
Public
Download the Special Bulletin: CMS Releases Proposed Rule on Medicaid Drug Value-based Purchasing Arrangements   The Centers for Medicare &…
Webinar Recordings
Member
A panel of 4 experts discussed federal policy emerging from Congress and the Administration under COVID-19 focusing on rural health priorities and took…
Letter/Comment
Public
Dear Secretary Azar: On behalf of our nearly 2,000 340B member hospitals, the American Hospital Association (AHA) urges the Department of Health and Human…